A Novel Curcumin Formulation, ASD-Cur, Suppressed the Development of Systolic Dysfunction After Myocardial Infarction
Hidemichi Takai1, Yoichi Sunagawa1,2,3, Masafumi Funamoto1,2
1University of Shizuoka Shizuoka, Japan.
European Cardiology
|February 2, 2022
Abstract
No abstract available in PubMed .


